The World Hepatitis Alliance published the findings of a global survey conducted in April 2020 to assess the effects of the COVID-19 crisis on viral hepatitis services and on people living with viral hepatitis.
- Only 47 (36%) of all 132 respondents reported that people were able to access viral hepatitis testing.
- 101 respondents gave reasons for lack of access to testing, with the main reason being closure of testing facilities and the prediction that public were avoiding going to testing facilities due to COVID-19.
- 23 (34%) of 68 respondents outside the USA reported that people on treatment for hepatitis were unable to access their medications at this time; and only 39 (30%) of 131 responses indicated adequate information on COVID-19 had been provided to people living with viral hepatitis in their country.
